1. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid

   • Mark T. J. van Bussel
   • Dick Pluim
   • Dieta Brandsma

   Topic Review 30 November 2017 Pages: 1 - 10

   

2. Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis

   • James Pan
   • Rashad Jabarkheel
   • Steven D. Chang

   Topic Review 04 December 2017 Pages: 11 - 22

   

3. P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures

   • Marjorie A. Curet
   • Jyoti J. Watters

   Laboratory Investigation 30 November 2017 Pages: 23 - 31

   

4. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma

   • Irene Paganini
   • Gabriele Lorenzo Capone
   • Laura Papi

   Laboratory Investigation 11 December 2017 Pages: 33 - 38

   

5. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

   • Arif N. Ali
   • Peixin Zhang
   • Walter J. Curran Jr

   Clinical Study 05 February 2018 Pages: 39 - 47

   

6. Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis

   • Lin Yang
   • Chuan-Jie Chen
   • Xiang-Yang Zhao

   Clinical Study Open access 23 November 2017 Pages: 49 - 56

   

7. Volumetric response of progressing post-SRS lesions treated with laser interstitial thermal therapy

   • Vivek B. Beechar
   • Sujit S. Prabhu
   • Ganesh Rao

   Clinical Study 04 December 2017 Pages: 57 - 65

   

8. Melanoma brain metastases harboring BRAF ^V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy

   • Penny Fang
   • Nicholas S. Boehling
   • Erik P. Sulman

   Clinical Study 02 December 2017 Pages: 67 - 75

   

9. Practice patterns and survival outcomes of intracranial germinoma: an analysis of the National Cancer Database

   • Wei Gang Wang
   • Hong Ye
   • Prakash Chinnaiyan

   Clinical Study 25 November 2017 Pages: 77 - 82

   

10. Outcome of children and adolescents with central nervous system tumors in phase I trials

    • Fernando Carceller
    • Francisco Bautista
    • Lynley V. Marshall

    Clinical Study 13 December 2017 Pages: 83 - 92

    

11. Pre-operative language ability in patients with presumed low-grade glioma

    • Malin Antonsson
    • Francesca Longoni
    • Lena Hartelius

    Clinical Study Open access 01 December 2017 Pages: 93 - 102

12. Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis

    • Cassie Kline
    • Erin Felton
    • Sabine Mueller

    Clinical Study 04 December 2017 Pages: 103 - 110

    

13. Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?

    • M. J. Lobon-Iglesias
    • G. Giraud
    • J. Grill

    Clinical Study 02 December 2017 Pages: 111 - 118

    

14. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy

    • Lea M. Ventura
    • Julie A. Grieco
    • Margaret B. Pulsifer

    Clinical Study 06 December 2017 Pages: 119 - 126

    

15. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas

    • Zenghui Qian
    • Yiming Li
    • Xing Liu

    Clinical Study 04 December 2017 Pages: 127 - 137

    

16. SNF5 as a prognostic factor in skull base chordoma

    • Mingxuan Li
    • Yixuan Zhai
    • Yazhuo Zhang

    Clinical Study 08 December 2017 Pages: 139 - 146

    

17. External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort

    • Roshan S. Prabhu
    • Robert H. Press
    • Stuart H. Burri

    Clinical Study 07 December 2017 Pages: 147 - 154

    

18. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology

    • Joseph R. Linzey
    • Bernard L. Marini
    • Carl Koschmann

    Clinical Study 12 December 2017 Pages: 155 - 169

    

19. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

    • Wenyin Shi
    • Erik S. Blomain
    • David W. Andrews

    Clinical Study 12 December 2017 Pages: 171 - 177

    

20. Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

    • Wenyin Shi
    • Erik S. Blomain
    • David W. Andrews

    Correction 08 January 2018 Pages: 179 - 179

21. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas

    • Te Whiti Rogers
    • Gurvinder Toor
    • Michael Gonzales

    Clinical Study 07 December 2017 Pages: 181 - 189

    

22. Internet-based guided self-help for glioma patients with depressive symptoms: a randomized controlled trial

    • Florien W. Boele
    • Martin Klein
    • On behalf of the Dutch Society for Neuro-Oncology (LWNO)

    Clinical Study Open access 13 December 2017 Pages: 191 - 203

    

23. Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care

    • Teresa de Rojas
    • Francisco Bautista
    • Lucas Moreno

    Clinical Study 16 December 2017 Pages: 205 - 213

    

24. A case of unusually long survival after leptomeningeal carcinomatosis diagnosis

    • Marianna Riolo
    • Emilio Ciusani
    • Andrea Salmaggi

    Letter to the Editor 02 December 2017 Pages: 215 - 218

    

25. Simpson grade IV resections of skull base meningiomas: does the postoperative tumor volume impact progression?

    • Benjamin Brokinkel
    • Walter Stummer
    • Peter Sporns

    Letter to the Editor 14 December 2017 Pages: 219 - 221